209 related articles for article (PubMed ID: 16732394)
1. A practical guide to dermatological drug use in pregnancy.
Zip C
Skin Therapy Lett; 2006 May; 11(4):1-4. PubMed ID: 16732394
[TBL] [Abstract][Full Text] [Related]
2. [Local treatment of dermatoses in pregnancy].
Arnold WP; Boelen RE; van de Kerkhof PC
Ned Tijdschr Geneeskd; 1995 Jun; 139(23):1170-3. PubMed ID: 7791922
[No Abstract] [Full Text] [Related]
3. [Maternal corticotherapy . Pharmacology and effect on the fetus].
Guillonneau M; Jacqz-Aigrain E
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):160-7. PubMed ID: 8690864
[TBL] [Abstract][Full Text] [Related]
4. [Topical therapy in pregnancy].
Zesch A
Hautarzt; 1990 Jul; 41(7):365-8. PubMed ID: 2205601
[TBL] [Abstract][Full Text] [Related]
5. Drugs and pregnancy.
Murphy JF
Ir Med J; 1984 Feb; 77(2):52-6. PubMed ID: 6370905
[No Abstract] [Full Text] [Related]
6. [Risks of topical treatments in pregnancy].
Machet L; Vaillant L; Lorette G
Ann Dermatol Venereol; 1992; 119(6-7):503-8. PubMed ID: 1444115
[No Abstract] [Full Text] [Related]
7. Dermatologic drugs, pregnancy, and lactation. A conservative guide.
Reed BR
Arch Dermatol; 1997 Jul; 133(7):894-8. PubMed ID: 9236528
[TBL] [Abstract][Full Text] [Related]
8. [Action of hormones and vitamins on the product of conception].
Moscolo GF; Fede T
Minerva Ginecol; 1973 Sep; 25(9):515-9. PubMed ID: 4776237
[No Abstract] [Full Text] [Related]
9. Caution advised in interpretation of US FDA risk classification for dermatological medications during pregnancy.
Wong JW; Heller MM; Murase JE
Dermatol Online J; 2012 Oct; 18(10):15. PubMed ID: 23122022
[TBL] [Abstract][Full Text] [Related]
10. [Effect of corticosteroids on pregnancy, the fetus and the newborn of the asthmatic woman].
Goldman J; Menkes J; Peleg D
Harefuah; 1978 Jan; 94(2):81-2. PubMed ID: 648956
[No Abstract] [Full Text] [Related]
11. [Dermatological treatment and pregnancy].
Piérard-Franchimont C; Gérardy-Goffin F; Piérard GE
Rev Med Liege; 1993 Sep; 48(9):505-11. PubMed ID: 8210844
[No Abstract] [Full Text] [Related]
12. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy.
Murase JE; Heller MM; Butler DC
J Am Acad Dermatol; 2014 Mar; 70(3):401.e1-14; quiz 415. PubMed ID: 24528911
[TBL] [Abstract][Full Text] [Related]
13. [The teratogenicity of dermatological treatments].
Henno A; De La Brassinne M
Ann Dermatol Venereol; 2004; 131(6-7 Pt 1):599-605. PubMed ID: 15318150
[No Abstract] [Full Text] [Related]
14. Common sense dermatological drug suggestions for women who are breast-feeding.
Zip C
Skin Therapy Lett; 2002 Mar; 7(3):5-7. PubMed ID: 12007012
[TBL] [Abstract][Full Text] [Related]
15. [Adverse reactions to externally applied drugs].
Honda M
Nihon Ika Daigaku Zasshi; 1984 Oct; 51(5):539-43. PubMed ID: 6238977
[No Abstract] [Full Text] [Related]
16. The topical corticosteroid classification called into question: towards a new approach.
Humbert P; Guichard A
Exp Dermatol; 2015 May; 24(5):393-5. PubMed ID: 25707534
[TBL] [Abstract][Full Text] [Related]
17. Safety classification systems used in dermatological medication risk counseling of pregnant and lactating patients: a case for an evidence-based approach.
Millsop JW; Heller MM; Murase JE
Dermatol Ther; 2013; 26(4):347-53. PubMed ID: 23914892
[TBL] [Abstract][Full Text] [Related]
18. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation.
Butler DC; Heller MM; Murase JE
J Am Acad Dermatol; 2014 Mar; 70(3):417.e1-10; quiz 427. PubMed ID: 24528912
[TBL] [Abstract][Full Text] [Related]
19. [Antineoplastic agents and pregnancy].
Grella P; Graziottin A; Sopracordevole F
Minerva Med; 1984 Jun; 75(27):1643-9. PubMed ID: 6462507
[TBL] [Abstract][Full Text] [Related]
20. Fetal pharmacotherapy.
Blackburn S
J Perinat Neonatal Nurs; 2008; 22(4):264-6. PubMed ID: 19011489
[No Abstract] [Full Text] [Related]
[Next] [New Search]
